Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.2c01920
Abstract: The histone lysine methyltransferase NSD2 is overexpressed, translocated, or mutated in multiple types of cancers and has emerged as an attractive therapeutic target. However, the development of small-molecule NSD2 inhibitors is still in its infancy,…
read more here.
Keywords:
modification pharmacological;
structural modification;
nsd2 inhibitors;
substituted quinoline ... See more keywords